ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO604

Polycystins Regulate Ezrin Function and Cleavage to Control Renal Cell and Tubular Morphology

Session Information

Category: Genetic Diseases of the Kidneys

  • 1201 Genetic Diseases of the Kidneys: Cystic

Authors

  • Zapf, Ava M., University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Dixon, Eryn E., University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Basquin, Denis, University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Watnick, Terry J., University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Woodward, Owen M., University of Maryland School of Medicine, Baltimore, Maryland, United States
Background

Renal cyst formation in ADPKD requires altered cell and tubular morphology. Previously, we used inducible inactivation of Pkd2 in a 3D-tubuloid model to measure acute changes in tubuloid shape after Pkd2 loss and observed alterations in tubule morphology before changes in overall volume, arguing that morphological changes are among the first consequences of polycystin loss. We hypothesized a direct role for the polycystin complex in regulating the apical cytoskeleton protein, ezrin (EZR), to control cell and tubular morphology.

Methods

We used clonal cell lines derived from the kidneys of Pkd1 or Pkd2 Pax8rtTA TetOCre mice crossed with the SV40 immorto-mouse: Pkd1-iKO (#313) and Pkd2-iKO (#125). Pkd1/2 can be efficiently deleted with addition of Doxycyline (DOX) to the cell media.

Results

We observed a strong correlation between the loss of Pkd1/2 and increased apical cell area, as defined by ZO1, in 2D Pkd1/2-iKO cells. The acute loss of Pkd1/2 also resulted in decreased ezrin abundance and altered localization. Although Pkd1/2 deletion resulted in decreased ezrin we found upregulation of Ezr mRNA in both the DOX treated Pkd2-iKO cells and in human ADPKD cystic tissue, leading us to hypothesize that PC1/2 regulates ezrin protein more directly. Immunoprecipitation experiments of HEK293 cells transfected with ezrin, Myc-PC2 or Flag-PC1 showed both PC1 and PC2 successfully pulled down ezrin sugesting a protein interaction. Interestingly, the pull down efficiency was greater with the full length PC1 than the CTF-PC1 fragment. To confirm an endogenous interaction between ezrin and PC1 we isolated primary renal epithelial cells from a transgenic Pkd1-HA mouse and found again HA-PC1 successfully pulled down ezrin. Mechanistically, ezrin activity is regulated by cystine proteases calpain 1 and 2. We observed a substantial increase in the N-terminal 55KDa ezrin cleavage product after acute Pkd2 loss in the DOX treated Pkd2-iKO cells as well in human APDKD cystic tissue. Chemical inhibition of either calpain 1 or calpain 2 led to increased ezrin cleavage in control cells mimicking Pkd2 loss. However, inhibition of both calpain 1 and 2 reduced ezrin cleavage in DOX treated Pkd2-iKO cells to levels comparable to control cells.

Conclusion

The polycystin proteins regulate ezrin function and cleavage to control renal cell and tubular morphology.

Funding

  • NIDDK Support